Ligands of Immunopharmacology

NLRP3 / aim2-in-2 is a new potent inhibitor with different species-specific effects on NLRP3 and AIM2 inflammasome dependent cell death. Its &lt b &gt IC &lt sub &gt 50 &lt / sub &gt &lt / b &gt value is 0.2392 ± 0.0233 μ

NLRP3 / aim2-in-2 is a new potent inhibitor with different species-specific effects on NLRP3 and AIM2 inflammasome dependent cell death. Its &lt b &gt IC &lt sub &gt 50 &lt / sub &gt &lt / b &gt value is 0.2392 ± 0.0233 μ

NLRP3 / aim2-in-2 is a new potent inhibitor with different species-specific effects on NLRP3 and AIM2 inflammasome dependent cell death. Its &lt b &gt IC &lt sub &gt 50 &lt / sub &gt &lt / b &gt value is 0.2392 ± 0.0233 μ M。IC50&amp

NOTA-FAPI is a fibroblast activation protein ( FAP ) inhibitor. NOTA-FAPI can be used as a probe for FAP-targeted tumour imaging. NOTA-FAPI has good tumour detection efficacy and excellent imaging quality.Form:Solid

NOTA-FAPI is a fibroblast activation protein ( FAP ) inhibitor. NOTA-FAPI can be used as a probe for FAP-targeted tumour imaging. NOTA-FAPI has good tumour detection efficacy and excellent imaging quality.Form:Solid

ODN 1018 (1018 ISS CpG 1018), an oligodeoxynucleotide, is a TLR-9 agonist. ODN 1018 is also a synthetic immunostimulatory sequence that can be used as vaccine adjuvant. Sequence: 5′-TGACTGTGAACGTTCGAGATGA-3′Form:SolidIC50&amp Target:TLR9

ODN 1018 (1018 ISS CpG 1018), an oligodeoxynucleotide, is a TLR-9 agonist. ODN 1018 is also a synthetic immunostimulatory sequence that can be used as vaccine adjuvant. Sequence: 5′-TGACTGTGAACGTTCGAGATGA-3′Form:SolidIC50&amp Target:TLR9

ODN 1018 (1018 ISS CpG 1018), an oligodeoxynucleotide, is a TLR-9 agonist. ODN 1018 is also a synthetic immunostimulatory sequence that can be used as vaccine adjuvant. Sequence: 5′-TGACTGTGAACGTTCGAGATGA-3′Form:SolidIC50&amp Target:TLR9

ODN 1668, a class B CpG ODN (oligodeoxynucleotide), is a TLR-9 agonist. ODN 1668 is an immunostimulatory sequence and can be used as vaccine adjuvant. Sequence: 5'-tccatgacgttcctgatgct-3’In VitroODN 1668 induces TNF-α secretion and promotes

ODN 1668, a class B CpG ODN (oligodeoxynucleotide), is a TLR-9 agonist. ODN 1668 is an immunostimulatory sequence and can be used as vaccine adjuvant. Sequence: 5'-tccatgacgttcctgatgct-3’In VitroODN 1668 induces TNF-α secretion and promotes

ODN 1826, a class B CpG ODN (oligodeoxynucleotide), is a TLR9 agonist. CpG ODN 1826 is an excellent immunostimulator that induces NO and iNOS production in the murine model. CpG ODN 1826 enhances cell apoptosis . ODN 1826 sequence:

ODN 1826, a class B CpG ODN (oligodeoxynucleotide), is a TLR9 agonist. CpG ODN 1826 is an excellent immunostimulator that induces NO and iNOS production in the murine model. CpG ODN 1826 enhances cell apoptosis . ODN 1826 sequence: